request Request a Protocol
ask Ask a question
Favorite

An MTT assay was performed to assess cell viability. K562 and IMR cells were treated with imatinib or MPT0B169 for the indicated time points, and the MTT assay was conducted as described previously [11].

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A